FdaApplication
ANDA 209267
Identifiers
- fda_app_no: ANDA209267
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2024-05-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | EQ 100MG BASE | TABLET;ORAL |
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | EQ 25MG BASE | TABLET;ORAL |
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | EQ 150MG BASE | TABLET;ORAL |
3 products